<DOC>
	<DOCNO>NCT01228240</DOCNO>
	<brief_summary>Background : Metformin usually use glycemic control type 2 diabetes mellitus . Different pharmaceutical type metformin available . As clinical trial , compare efficacy complication metformin produce `` Pars Mino pharmaceutical company , Iran '' `` Apotex pharmaceutical company , Canada '' , type 2 diabetic patient . Method : 18 eligible woman type 2 diabetes give metformin `` Pars Mino '' `` Apotex '' ( 500 mg twice day ) 6 week period randomize , double blind , crossover study . After 2 week washout period another 6 week period another Brand metformin prescribed . FBS , HbA1C , lipid profile ( Cholesterol , TG , HDL , LDL ) , weight , BMI assess treatment phase . The result compare paired sample T-test , Independent sample T-test .</brief_summary>
	<brief_title>The Efficacy Metformin Produced Pars Mino Co Comparison With Canadian Apotex Co. Glycemic Control Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Mild hyperglycemia , contraindication metformin , poor control diabetes Creatinine 1.5 , severe organ damage</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Diabetes mellitus , type 2 , Metformin , Generic , Efficacy</keyword>
</DOC>